- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 9/02 - Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Patent holdings for IPC class A61P 9/02
Total number of patents in this class: 286
10-year publication summary
|
8
|
9
|
19
|
24
|
24
|
28
|
23
|
19
|
16
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nevakar Injectables Inc. | 43 |
11 |
| F. Hoffmann-La Roche AG | 7921 |
8 |
| La Jolla Pharma,llc | 14 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4253 |
5 |
| Genentech, Inc. | 3980 |
4 |
| Boehringer Ingelheim International GmbH | 4648 |
4 |
| Bayer Pharma AG | 1047 |
4 |
| Amgen Inc. | 4044 |
4 |
| Daiichi Sankyo Company, Limited | 1874 |
4 |
| Novartis AG | 10850 |
3 |
| Takeda Pharmaceutical Company Limited | 2709 |
3 |
| BIAL - Portela & CA, S.A. | 220 |
3 |
| Children's Medical Center Corporation | 1864 |
3 |
| Tersera Therapeutics LLC | 64 |
3 |
| The Trustees of Indiana University | 739 |
3 |
| University of Washington | 2330 |
3 |
| Yale University | 2385 |
3 |
| Theravance Biopharma R&D IP, LLC | 458 |
3 |
| Rainbow Engineering Services | 3 |
3 |
| Allergan, Inc. | 2346 |
2 |
| Other owners | 202 |